By Karl Hofmann, President & CEO, PSI and Mario Raviglione, Director of Global TB Programme, WHO “End TB!” Over the past 20 years, that rallying cry has gone from fantasy to imperative. Since the advent of the World Health Organization’s directly observed treatment strategy in 1995, more than 61 million people have been successfully treated for tuberculosis, and newRead More ›
By: Jackie Presutti, Associate, Corporate Partnerships & Philanthropy “Few of our challenges are going to be addressed unilaterally, and most will be solved through successful partnership,” said Karl Hofmann, President and CEO of PSI during a live webcast on Thursday. The webcast, hosted by PYXERA Global, was part of a weeklong series of events inRead More ›
The annual World Economic Forum gathering in Davos, Switzerland, is happening this week. PSI President and CEO Karl Hofmann is there making sure global health issues get the attention they deserve from global business and political leaders. He spent a few minutes with HubCulture.com’s Edie Lush speaking about the good and bad news about the ongoing EbolaRead More ›
By Karl Hofmann and Simon Cooke World Health Organization Director-General Dr. Margaret Chan calls universal health coverage (UHC) “the single most powerful concept that public health has to offer.” But what is UHC? Officially, UHC means that every person, everywhere, has access to health care without suffering financial hardship. Indeed the World Bank, once a staunch advocateRead More ›
Unlike the empathy that characterizes the reaction to a natural disaster like a hurricane or earthquake, the public response to Ebola has been driven by fear. The result has been a lack of support for much-needed relief efforts. Companies are joining NGOs, philanthropic partners and public sector leaders to change that. “I don’t know that I’veRead More ›
PSI and Unilever are teaming up once again to support achievement of MDGs and building stronger, healthier societies. By partnering with Haitian micro-finance organization Fonkoze, the three organizations aim to support communities across the country in their efforts to build a better future. This new partnership combines the strengths of the three organizations: Unilever’s health and hygieneRead More ›
How private sector providers add marketing and distribution value for voluntary medical male circumcision
By Oscar Abello President Barack Obama. Former Kenya Prime Minister Raila Odinga. Oscar-award winning actress Lupita Nyong’o. They’re not just of Kenyan heritage—all three are specifically of Luo heritage, the third largest ethnic group in Kenya, predominantly residing in the Nyanza province on the shores of Lake Victoria in Kenya’s western region. The Luo standoutRead More ›
Lining up to eliminate a major threat to humankind – Part 3
PSI Senior Vice President for Malaria Control and Child Survival Dr. Desmond Chavasse blogs about his recent trip to Cambodia and PSI’s work to eliminate drug-resistant malaria in Southeast Asia. Below is part 3 of 3. (read part 1 or part 2) PSI, and others, have learned a great deal about malaria in Southeast Asia with the helpRead More ›
Lining up to eliminate a major threat to humankind – Part 2
PSI Senior Vice President for Malaria Control and Child Survival Dr. Desmond Chavasse blogs about his recent trip to Cambodia and PSI’s work to eliminate drug-resistant malaria in Southeast Asia. Below is part 2 of 3. (read part 1) After Bill and Melinda Gates visited PSI in Cambodia, I spent several days there with myRead More ›
Lining up to eliminate a major threat to humankind - Part 1
PSI Senior Vice President for Malaria Control and Child Survival Dr. Desmond Chavasse blogs about his recent trip to Cambodia and PSI’s work to eliminate drug-resistant malaria in Southeast Asia. Below is part 1 of 3. Why Malaria, Why Southeast Asia, Why now? I first met Bill Gates for dinner in Nairobi in 2008. HisRead More ›
By Brian Smith, originally posted at NextBillion.net.
Editor’s note: NextBillion Health Care has launched a new Market Dynamics initiative to encourage discussion about how markets impact health outcomes.
Why are so many global public health experts talking about “market dynamics” these days?
Whether we call it “market shaping” or “market facilitation” or the “total market approach,” there is a large and growing interest in the idea that we’ll be more effective in improving health outcomes at the base of the pyramid if we frame challenges in terms of markets. Why?Read More ›
As a global health community, we have the skills and know-how to accomplish these goals, but we must work together and recognize that the ‘secret ingredient’ that binds all of our collective knowledge, skills and interventions is a strong health system. The Lancet Commission on Investing in Health reported this past year that such goals are indeed feasible and would bring about a grand convergence in life expectancy between poor and rich nations in our lifetime. The required investment would pay off 9 to 20 times in full-income returns, and to succeed, half of the resources should be used to strengthen health systems – from human resources to better governance of the sector’s public and private components.Read More ›